Skip to main content
. 2019 Feb 12;13(2):197–205. doi: 10.5009/gnl18204

Fig. 1.

Fig. 1

Cumulative incidence rates of hepatocellular carcinoma (HCC) based on antiviral therapy (AVT) status at enrollment. The cumulative HCC incidence rates were not significantly different based on the AVT status at enrollment (p=0.076 by the log-rank test).